Bomb Report – Lifestyle
Author:
uniQure Inc.
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
April 30, 2026
uniQure to Announce First Quarter 2026 Financial Results
April 28, 2026
uniQure Announces 2025 Financial Results and Provides Recent Company Updates
March 6, 2026
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
March 6, 2026